SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-15-198808
Filing Date
2015-05-22
Accepted
2015-05-22 16:40:01
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d931600dsc14d9.htm SC 14D9 426303
2 EX-99.(E)(2) d931600dex99e2.htm EX-99.(E)(2) 422681
3 EX-99.(E)(10) d931600dex99e10.htm EX-99.(E)(10) 3563
4 GRAPHIC g931600g03o29.jpg GRAPHIC 23142
  Complete submission text file 0001193125-15-198808.txt   886280
Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filed by) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Subject) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-52299 | Film No.: 15887092
SIC: 2836 Biological Products, (No Diagnostic Substances)